NL8701335A - Orale farmaceutische preparaten. - Google Patents

Orale farmaceutische preparaten. Download PDF

Info

Publication number
NL8701335A
NL8701335A NL8701335A NL8701335A NL8701335A NL 8701335 A NL8701335 A NL 8701335A NL 8701335 A NL8701335 A NL 8701335A NL 8701335 A NL8701335 A NL 8701335A NL 8701335 A NL8701335 A NL 8701335A
Authority
NL
Netherlands
Prior art keywords
minutes
percent
ketotifene
pharmaceutical composition
granular
Prior art date
Application number
NL8701335A
Other languages
English (en)
Dutch (nl)
Original Assignee
Sandoz Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz Ag filed Critical Sandoz Ag
Publication of NL8701335A publication Critical patent/NL8701335A/nl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
NL8701335A 1986-06-21 1987-06-09 Orale farmaceutische preparaten. NL8701335A (nl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE3620830 1986-06-21
DE3620830 1986-06-21

Publications (1)

Publication Number Publication Date
NL8701335A true NL8701335A (nl) 1988-01-18

Family

ID=6303418

Family Applications (1)

Application Number Title Priority Date Filing Date
NL8701335A NL8701335A (nl) 1986-06-21 1987-06-09 Orale farmaceutische preparaten.

Country Status (30)

Country Link
US (1) US5399360A (fr)
JP (2) JPS638332A (fr)
KR (1) KR880000095A (fr)
AT (1) AT400521B (fr)
AU (1) AU611637B2 (fr)
BE (1) BE1000661A4 (fr)
CA (1) CA1314227C (fr)
CH (3) CH672735A5 (fr)
CY (1) CY1589A (fr)
DE (1) DE3719818C2 (fr)
DK (1) DK314387A (fr)
ES (1) ES2006170A6 (fr)
FI (1) FI872733A (fr)
FR (1) FR2600253B1 (fr)
GB (1) GB2191696B (fr)
GR (1) GR870965B (fr)
HK (1) HK27691A (fr)
HU (1) HU202753B (fr)
IE (1) IE59178B1 (fr)
IL (1) IL82924A (fr)
IT (1) IT1216822B (fr)
LU (1) LU86928A1 (fr)
MY (1) MY101566A (fr)
NL (1) NL8701335A (fr)
NO (1) NO872551L (fr)
NZ (1) NZ220769A (fr)
PH (1) PH26313A (fr)
PT (1) PT85128B (fr)
SE (1) SE8702563L (fr)
ZA (1) ZA874450B (fr)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5891460A (en) * 1995-06-07 1999-04-06 University Of Southern California University Park Campus Method for reducing or preventing post-surgical adhesion formation using ketotifen and analogs thereof
US6207684B1 (en) 1997-06-09 2001-03-27 Bridge Pharma, Inc. Compounds with combined antihistaminic and mast cell stabilizing activities, intended for ophthalmic use
US6740889B1 (en) * 1998-09-28 2004-05-25 Applied Materials, Inc. Charged particle beam microscope with minicolumn
WO2001039774A1 (fr) * 1999-12-01 2001-06-07 Klein Pharmaceuticals Administration topique de ketotifene
US20030153620A1 (en) 2000-05-12 2003-08-14 Meakin Timothy David Treating eczema and/or psoriasis
NZ514536A (en) * 2001-09-28 2005-02-25 Meracol Corp Ltd Use of cetyl myristate and/or cetyl palmitate to treat asthma, chronic obstructive pulmonary disease and/or other respiratory difficulties
ITMI20012366A1 (it) * 2001-11-09 2003-05-09 Farmatron Ltd Sistemi terapeutici stabilizzati a rilascio immediato e/o modificato per la somministrazione orale di principi attivi e/o eccipienti e/o ali
JP4867128B2 (ja) * 2002-10-01 2012-02-01 大正製薬株式会社 経口鼻炎治療用組成物
AU2005320547B2 (en) * 2004-12-27 2009-02-05 Eisai R & D Management Co., Ltd. Method for stabilizing anti-dementia drug
US20060160852A1 (en) * 2004-12-27 2006-07-20 Eisai Co. Ltd. Composition containing anti-dementia drug
US20090208579A1 (en) * 2004-12-27 2009-08-20 Eisai R & D Management Co., Ltd. Matrix Type Sustained-Release Preparation Containing Basic Drug or Salt Thereof, and Method for Manufacturing the Same
US20070129402A1 (en) * 2004-12-27 2007-06-07 Eisai Research Institute Sustained release formulations
US20060280789A1 (en) * 2004-12-27 2006-12-14 Eisai Research Institute Sustained release formulations
US20060159753A1 (en) * 2004-12-27 2006-07-20 Eisai Co. Ltd. Matrix type sustained-release preparation containing basic drug or salt thereof
US20060246003A1 (en) * 2004-12-27 2006-11-02 Eisai Co. Ltd. Composition containing anti-dementia drug
WO2008153761A1 (fr) * 2007-05-23 2008-12-18 Mastcell Pharmaceuticals, Inc. Méthodes
WO2009142772A2 (fr) * 2008-05-23 2009-11-26 Mastcell Pharmaceuticals, Inc. Méthodes et traitement d’allergies et inflammations associées à des pathologies gastro-intestinales
EP2441445A1 (fr) * 2010-10-14 2012-04-18 Deva Holding Anonim Sirketi Revêtement de particules de cetyl myristate et/ou cetyl palmitate

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH531000A (de) * 1970-03-11 1972-11-30 Sandoz Ag Verfahren zur Herstellung neuer Benzocycloheptathiophene
DE2360796B2 (de) * 1973-12-06 1977-06-02 Edelfettwerke Werner Schlüter, 2000 Hamburg; Glyco Iberica S.A., Gava, Barcelona (Spanien) Vti: Hegel, K.Th., Dr.; Dickel, K., Dipl.-Ing.; Pat.-Anwälte, 2000 Hamburg und 8000 München Arzneimittel mit verzoegerter abgabe des wirkstoffs im darm
DE2426811A1 (de) * 1974-06-04 1976-01-08 Klinge Co Chem Pharm Fab Verfahren zur herstellung von retard-tabletten
US4073915A (en) * 1975-05-20 1978-02-14 Sandoz Ltd. Treating asthma
JPS51142543A (en) * 1975-05-20 1976-12-08 Sandoz Ag Improvement in organic compound
FR2440371A1 (fr) * 1978-10-31 1980-05-30 Fisons Ltd Nouveaux composes azotes heterocycliques, des compositions pharmaceutiques en contenant et des procedes pour les preparer
GB2154874B (en) * 1984-02-29 1987-11-04 Sandoz Ltd Bromoscriptine compositions
WO1985003878A1 (fr) * 1984-03-01 1985-09-12 Sandoz Ag Compositions pharmaceutiques
DE3421468A1 (de) * 1984-06-08 1985-12-19 Dr. Rentschler Arzneimittel Gmbh & Co, 7958 Laupheim Lipidnanopellets als traegersystem fuer arzneimittel zur peroralen anwendung
IT1200102B (it) * 1984-08-16 1989-01-05 Sandoz Ag Preparazioni farmaceutiche comprendenti chetotifere ed una xartina ad azione antiasmatica in combinazione fissa
US5069911A (en) * 1985-02-05 1991-12-03 Sandoz Ltd. Pharmaceutical 9,10-dihydrogenated ergot alkaloid containing compositions
DE3505433A1 (de) * 1985-02-16 1986-08-21 Basf Ag, 6700 Ludwigshafen Direkttablettierhilfsmittel
FR2581541B1 (fr) * 1985-05-09 1988-05-20 Rhone Poulenc Sante Nouvelles compositions pharmaceutiques permettant la liberation prolongee d'un principe actif et leur procede de preparation
US4797286A (en) * 1985-11-12 1989-01-10 Eli Lilly And Company Orally administerable sustained release pharmaceutical formulations
US4798725A (en) * 1986-06-16 1989-01-17 Norwich Eaton Pharmaceuticals, Inc. Sustained release capsule

Also Published As

Publication number Publication date
IE871634L (en) 1987-12-21
BE1000661A4 (fr) 1989-03-07
GB2191696A (en) 1987-12-23
CY1589A (en) 1992-04-03
JP2860013B2 (ja) 1999-02-24
FR2600253A1 (fr) 1987-12-24
GB8714131D0 (en) 1987-07-22
FR2600253B1 (fr) 1990-01-26
US5399360A (en) 1995-03-21
NO872551D0 (no) 1987-06-18
SE8702563L (sv) 1987-12-22
NZ220769A (en) 1990-12-21
AU611637B2 (en) 1991-06-20
KR880000095A (ko) 1988-03-23
IT1216822B (it) 1990-03-14
MY101566A (en) 1991-12-17
FI872733A (fi) 1987-12-22
CA1314227C (fr) 1993-03-09
ES2006170A6 (es) 1989-04-16
ATA156187A (de) 1995-06-15
CH672735A5 (fr) 1989-12-29
PT85128B (pt) 1990-03-30
IL82924A0 (en) 1987-12-20
PT85128A (en) 1987-07-01
CH676201A5 (fr) 1990-12-28
AT400521B (de) 1996-01-25
DK314387D0 (da) 1987-06-19
HUT47428A (en) 1989-03-28
JPH05246849A (ja) 1993-09-24
DE3719818C2 (de) 1997-02-13
JPS638332A (ja) 1988-01-14
CH674805A5 (fr) 1990-07-31
DE3719818A1 (de) 1987-12-23
LU86928A1 (fr) 1988-01-20
GB2191696B (en) 1991-01-16
ZA874450B (en) 1989-01-25
IL82924A (en) 1992-11-15
HK27691A (en) 1991-04-19
DK314387A (da) 1987-12-22
IE59178B1 (en) 1994-01-26
PH26313A (en) 1992-04-23
NO872551L (no) 1987-12-22
GR870965B (en) 1987-10-20
FI872733A0 (fi) 1987-06-18
IT8748075A0 (it) 1987-06-19
SE8702563D0 (sv) 1987-06-18
AU7452587A (en) 1987-12-24
HU202753B (en) 1991-04-29

Similar Documents

Publication Publication Date Title
AU2019204689B2 (en) Solid dosage forms of palbociclib
NL8701335A (nl) Orale farmaceutische preparaten.
KR101151011B1 (ko) 테노포비어, 계면 활성제, 에파비렌즈와 엠트리씨타빈을함유하는, 안정한 고정 투여량의 단위 제형
US7741374B1 (en) Methods of use of fenofibric acid
KR101181172B1 (ko) 방출성이 제어된 시간차 투여 약제학적 제제
US20120015032A1 (en) Combination preparation comprising inhibitor of hmg-coa reductase and aspirin and method for manufacturing the same
EA037375B1 (ru) Составы с замедленным высвобождением, содержащие колхицин, и способы их применения
NL8501578A (nl) Nieuwe galenische retardvorm.
RU2724338C2 (ru) Фармацевтическая комплексная композиция, включающая амлодипин, лозартан и розувастатин
KR20090015890A (ko) 저 홍조 니아신 제형
JP6866136B2 (ja) デュロキセチン塩酸塩を含む口腔内崩壊錠
BG64839B1 (bg) Контролирано освобождаващи перорални състави на левосимендан
JP4945043B2 (ja) モルシドミンの放出時間延長を伴う経口投与用新規生薬製剤
NL194822C (nl) Preparaat voor orale toediening met geregelde afgifte en werkwijze voor de bereiding ervan.
KR102391495B1 (ko) 안정성 및 용출율이 개선된 타다라필 및 탐수로신 함유 캡슐 복합제제
EP3727344A1 (fr) Compositions pharmaceutiques à doses fixes comprenant de l'amlodipine, du ramipril et de l'atorvastatine
KR950007229B1 (ko) 케토티펜을 함유한 약학적 조성물
WO2024047208A1 (fr) Thérapie anticoagulante avec un régime posologique amélioré
AU598751B2 (en) Pharmaceutical formulations with controlled release of the active substance
CA2812968A1 (fr) Preparation pharmaceutique contenant de la phenytoine sodium et du stearate de magnesium

Legal Events

Date Code Title Description
BA A request for search or an international-type search has been filed
BB A search report has been drawn up
BC A request for examination has been filed
CNR Transfer of rights (patent application after its laying open for public inspection)

Free format text: NOVARTIS AG

BV The patent application has lapsed